159 related articles for article (PubMed ID: 32602487)
1. [Ru(phen)
Li R; Ma Y; Hu X; Wu W; Wu X; Dong C; Shi S; Lin Y
Dalton Trans; 2020 Jul; 49(26):8864-8871. PubMed ID: 32602487
[TBL] [Abstract][Full Text] [Related]
2. Anticancer activity of ruthenium(II) plumbagin complexes with polypyridyl as ancillary ligands via inhibiting energy metabolism and GADD45A-mediated cell cycle arrest.
Li YL; Zhu XM; Chen NF; Chen ST; Yang Y; Liang H; Chen ZF
Eur J Med Chem; 2022 Jun; 236():114312. PubMed ID: 35421660
[TBL] [Abstract][Full Text] [Related]
3. Near-IR/Visible-Emitting Thiophenyl-Based Ru(II) Complexes: Efficient Photodynamic Therapy, Cellular Uptake, and DNA Binding.
Zhang SQ; Meng TT; Li J; Hong F; Liu J; Wang Y; Gao LH; Zhao H; Wang KZ
Inorg Chem; 2019 Oct; 58(20):14244-14259. PubMed ID: 31595752
[TBL] [Abstract][Full Text] [Related]
4. Synthesis, characterization and biological evaluation of labile intercalative ruthenium(ii) complexes for anticancer drug screening.
Huang H; Zhang P; Chen Y; Qiu K; Jin C; Ji L; Chao H
Dalton Trans; 2016 Aug; 45(33):13135-45. PubMed ID: 27294337
[TBL] [Abstract][Full Text] [Related]
5. Visible-Light-Responsive Novel Ru(II)-Metallo-Antibiotics with Potential Antibiofilm and Antibacterial Activity.
Mandal AA; Upadhyay A; Mandal A; Nayak M; K MS; Mukherjee S; Banerjee S
ACS Appl Mater Interfaces; 2024 Jun; 16(22):28118-28133. PubMed ID: 38783713
[TBL] [Abstract][Full Text] [Related]
6. Niacin-ligated platinum(iv)-ruthenium(ii) chimeric complexes synergistically suppress tumor metastasis and growth with potentially reduced toxicity in vivo.
Shu L; Ren L; Wang Y; Fang T; Ye Z; Han W; Chen C; Wang H
Chem Commun (Camb); 2020 Mar; 56(20):3069-3072. PubMed ID: 32049075
[TBL] [Abstract][Full Text] [Related]
7. Ruthenium(II) Phosphine/Mercapto Complexes: Their in Vitro Cytotoxicity Evaluation and Actions as Inhibitors of Topoisomerase and Proteasome Acting as Possible Triggers of Cell Death Induction.
Ribeiro GH; Guedes APM; de Oliveira TD; de Correia CRSTB; Colina-Vegas L; Lima MA; Nóbrega JA; Cominetti MR; Rocha FV; Ferreira AG; Castellano EE; Teixeira FR; Batista AA
Inorg Chem; 2020 Oct; 59(20):15004-15018. PubMed ID: 32997499
[TBL] [Abstract][Full Text] [Related]
8. Ruthenium(II) Diphosphine Complexes with Mercapto Ligands That Inhibit Topoisomerase IB and Suppress Tumor Growth In Vivo.
da Silva MM; Ribeiro GH; de Camargo MS; Ferreira AG; Ribeiro L; Barbosa MIF; Deflon VM; Castelli S; Desideri A; Corrêa RS; Ribeiro AB; Nicolella HD; Ozelin SD; Tavares DC; Batista AA
Inorg Chem; 2021 Sep; 60(18):14174-14189. PubMed ID: 34477373
[TBL] [Abstract][Full Text] [Related]
9. Synthesis, Characterization, and Inducing Tumor Cell Apoptosis of Two Ru(II) Complexes Containing Guanidinium as Ligands.
Sun J; Chen WX; Song XD; He SF; Chen JX; Mei J; Zhu XX; Wu T
Anticancer Agents Med Chem; 2018; 18(1):110-120. PubMed ID: 28425859
[TBL] [Abstract][Full Text] [Related]
10. Cyclometalated Ru(II)-isoquinoline complexes overcome cisplatin resistance of A549/DDP cells by downregulation of Nrf2 via Akt/GSK-3β/Fyn pathway.
Chen L; Wang J; Cai X; Chen S; Zhang J; Li B; Chen W; Guo X; Luo H; Chen J
Bioorg Chem; 2022 Feb; 119():105516. PubMed ID: 34856444
[TBL] [Abstract][Full Text] [Related]
11. A nuclear permeable Ru(ii)-based photoactivated chemotherapeutic agent towards a series of cancer cells: in vitro and in vivo studies.
Tian N; Feng Y; Sun W; Lu J; Lu S; Yao Y; Li C; Wang X; Zhou Q
Dalton Trans; 2019 May; 48(19):6492-6500. PubMed ID: 30994660
[TBL] [Abstract][Full Text] [Related]
12. Synthesis, anticancer and antibacterial activity of some novel mononuclear Ru(II) complexes.
Mazumder UK; Gupta M; Karki SS; Bhattacharya S; Rathinasamy S; Thangavel S
Chem Pharm Bull (Tokyo); 2004 Feb; 52(2):178-85. PubMed ID: 14758001
[TBL] [Abstract][Full Text] [Related]
13. Mononuclear η
Kanyora AK; Omondi RO; Ongoma P; Omolo JO; Welsh A; Prince S; Gichumbi J; Mambanda A; Smith GS
J Biol Inorg Chem; 2024 Mar; 29(2):251-264. PubMed ID: 38494554
[TBL] [Abstract][Full Text] [Related]
14. Enantiomeric selectivity of ruthenium (II) chiral complexes with antitumor activity, in vitro and in vivo.
Zhang W; Sun Y; Wang J; Ding X; Yang E; Martin LL; Sun D
J Inorg Biochem; 2021 Mar; 216():111339. PubMed ID: 33388703
[TBL] [Abstract][Full Text] [Related]
15. Synthesis, RNA-sequence and evaluation of anticancer efficacy of ruthenium(II) polypyridyl complexes toward HepG2 cells.
Hu H; Zhang H; Zhong R; Yang Y; Huang C; Chen J; Liang L; Chen Y; Liu Y
J Inorg Biochem; 2023 Jul; 244():112230. PubMed ID: 37084581
[TBL] [Abstract][Full Text] [Related]
16. Green Light-Triggered Photocatalytic Anticancer Activity of Terpyridine-Based Ru(II) Photocatalysts.
Mandal AA; Singh V; Saha S; Peters S; Sadhukhan T; Kushwaha R; Yadav AK; Mandal A; Upadhyay A; Bera A; Dutta A; Koch B; Banerjee S
Inorg Chem; 2024 Apr; 63(16):7493-7503. PubMed ID: 38578920
[TBL] [Abstract][Full Text] [Related]
17. Cyclometalated Ru(II)-NHC complexes with phenanthroline ligands induce apoptosis mediated by mitochondria and endoplasmic reticulum stress in cancer cells.
Chen C; Lv H; Xu H; Zhu D; Shen C
Dalton Trans; 2023 Feb; 52(6):1671-1679. PubMed ID: 36648504
[TBL] [Abstract][Full Text] [Related]
18. Lysosome-targeted ruthenium(II) complexes induce both apoptosis and autophagy in HeLa cells.
Pan NL; Liao JX; Huang MY; Zhang YQ; Chen JX; Zhang ZW; Yang ZX; Long XE; Wu XT; Sun J
J Inorg Biochem; 2022 Apr; 229():111729. PubMed ID: 35066350
[TBL] [Abstract][Full Text] [Related]
19. Labile ruthenium(ii) complexes with extended phenyl-substituted terpyridyl ligands: synthesis, aquation and anticancer evaluation.
Huang H; Zhang P; Chen Y; Ji L; Chao H
Dalton Trans; 2015 Sep; 44(35):15602-10. PubMed ID: 26245234
[TBL] [Abstract][Full Text] [Related]
20. Effect of
Mukherjee A; Acharya S; Purkait K; Chakraborty K; Bhattacharjee A; Mukherjee A
Inorg Chem; 2020 May; 59(9):6581-6594. PubMed ID: 32295347
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
